Wesley Choi is an associate in the Transactions Practice group in the firm’s San Francisco office, and is a member of the Innovative Technology, Health Care and Life Sciences sectors. She focuses her practice on advising emerging growth and startup companies, venture capital, private equity and other investors on entity formation, equity financings, buyouts, dispositions and general corporate counseling matters.
Wesley has represented a wide range of emerging growth companies and their investors in venture capital, growth equity and other financings, mergers, acquisitions and other corporate matters.
Wesley has also led various pro bono initiatives in the areas of immigration, election law, as well as nonprofit incorporation and governance.
Languages
- Korean
Foley Represents LG Technology Ventures as a Lead Investor in $36 Million Series B Round for Li Industries
Foley & Lardner LLP represented LG Technology Ventures as a lead investor in the $36 million Series B funding round for Li Industries.
Foley Represents TDK Ventures as Lead Investor in Series A Funding Round for Faction Technology
Foley & Lardner LLP represented TDK Ventures as the lead investor in the Series A financing for driverless-technology developer Faction Technology.
Foley Represents Envisioning Partners as Lead Investor in Series A Funding for Dimensional Energy
Foley & Lardner LLP represented Envisioning Partners as the lead investor in the Series A financing for Dimensional Energy, a global leader in carbon utilization technology, Sustainable Aviation Fuel production, and advanced carbon emissions-derived fuels and materials.
Foley Represents True North in Minority Investment in iLink Digital
Foley & Lardner LLP acted as international legal counsel to True North, an India-based private equity firm, in its investment of $75 million for a minority stake in iLink Digital, a leading provider of digital transformation solutions.
Foley Represents Bioluminescence Ventures as Lead Investor in ReCode Therapeutics Series B Funding Extension
Foley & Lardner LLP represented Bioluminescence Ventures as the lead investor in the $50 million Series B funding extension for ReCode Therapeutics.
Foley Represents Altis Movement Technologies in Sale of Groundbreaking Human Motion Capture Assets
Foley & Lardner LLP represented Altis Movement Technologies in the sale of their groundbreaking human motion capture assets to Academy Medtech Ventures. Altis is a human kinematics AI and computer vision company responsible for the first Movement Operating System, Movement OS.